Cargando…

2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF

BACKGROUND: Daptomycin (DAP) resistance in enterococci is regulated by the LiaFSR three-component regulatory system. Mutations in liaF have been linked to activation of this system, with increased expression of the protein LiaX, and resistance to DAP in clinical isolates. LiaX functions by recognizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Botero, Diana Panesso, Singh, Kavindra, Gomez-Villegas, Sara-Isabel, Khan, Ayesha, Supande, Adeline, Nguyen, April, Rincon, Sandra, Hood, Kara S, Dinh, An, Deyanov, Alexander, Miller, William R, Shamoo, Yousif, Tran, Cecilia, Arias, Cesar A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752123/
http://dx.doi.org/10.1093/ofid/ofac492.157
_version_ 1784850642672549888
author Botero, Diana Panesso
Singh, Kavindra
Gomez-Villegas, Sara-Isabel
Khan, Ayesha
Supande, Adeline
Nguyen, April
Rincon, Sandra
Hood, Kara S
Dinh, An
Deyanov, Alexander
Miller, William R
Shamoo, Yousif
Tran, Cecilia
Arias, Cesar A
author_facet Botero, Diana Panesso
Singh, Kavindra
Gomez-Villegas, Sara-Isabel
Khan, Ayesha
Supande, Adeline
Nguyen, April
Rincon, Sandra
Hood, Kara S
Dinh, An
Deyanov, Alexander
Miller, William R
Shamoo, Yousif
Tran, Cecilia
Arias, Cesar A
author_sort Botero, Diana Panesso
collection PubMed
description BACKGROUND: Daptomycin (DAP) resistance in enterococci is regulated by the LiaFSR three-component regulatory system. Mutations in liaF have been linked to activation of this system, with increased expression of the protein LiaX, and resistance to DAP in clinical isolates. LiaX functions by recognizing DAP in the extracellular medium, and serves as a signal transduction molecule. However, the role of LiaF in signaling and its relationship with LiaX are unknown. METHODS: We generated a liaF null mutant in E. faecalis OG117 by adding four stop codons at amino acid positions 11–14 (OG117liaF*(11-14)) using a CRISPR-Cas9 system. The mutant was complemented by restoring wild-type liaF in its chromosomal location (OG117liaF*(11-14)::liaF). Mutants were confirmed with whole genome sequencing (WGS). Anionic phospholipid (AP) microdomain distribution was assessed on microscopy using 10-N-nonyl-acridine-orange (NAO). LiaFSR activation was assessed by surface expression of LiaX via ELISA. DAP MICs were performed by broth microdilution in the presence/absence of exogenous LiaX (eLiaX). LL37 (50µg/ml) and DAP (1.5µg/ml) killing assays with eLiaX were also performed in triplicate. RESULTS: Truncation of liaF did not have any effect on DAP MICs, AP microdomain distribution or LiaX surface expression compared to OG117. No additional mutations were observed by WGS in the mutants. In the presence eLiaX, DAP MIC increased 8-fold in wild-type OG117 but remained the same (1 µg/mL) in OG117liaF*(11-14). Complementation of liaF restored the increase in DAP MIC in the presence of eLiaX. In the LL37 killing assay, survival of OG117 was significantly increased on the addition of eLiaX (2.9% vs 11.8%, respectively, P < .002). Addition of eLiaX was unable to rescue OG117liaF*(11-14) in the presence of LL-37 (2.4% vs 2.5% respectively, P=0.51), but was able to increase survival in the complemented strain (2.8% vs 7.6%, respectively, P < .002). A similar trend was seen in the DAP killing assay, with increased survival for OG117 (8.7% vs 20%) and OG117liaF*(11-14)::liaF (11.6% vs 17%), but not OG117liaF*(11-14) (0.38% vs 1%). CONCLUSION: LiaF is required for full tolerance to the cathelicidin LL37 and DAP in E. faecalis OG1RF. These results suggest that LiaF may interact with LiaX as a part of the LiaFSR stress response. DISCLOSURES: William R. Miller, MD, Entasis: Grant/Research Support|UpToDate: Honoraria Cesar A. Arias, MD, PhD, Entasis: Grant/Research Support|MeMed Diagnostics Ltd: Grant/Research Support|Merck: Grant/Research Support.
format Online
Article
Text
id pubmed-9752123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97521232022-12-16 2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF Botero, Diana Panesso Singh, Kavindra Gomez-Villegas, Sara-Isabel Khan, Ayesha Supande, Adeline Nguyen, April Rincon, Sandra Hood, Kara S Dinh, An Deyanov, Alexander Miller, William R Shamoo, Yousif Tran, Cecilia Arias, Cesar A Open Forum Infect Dis Abstracts BACKGROUND: Daptomycin (DAP) resistance in enterococci is regulated by the LiaFSR three-component regulatory system. Mutations in liaF have been linked to activation of this system, with increased expression of the protein LiaX, and resistance to DAP in clinical isolates. LiaX functions by recognizing DAP in the extracellular medium, and serves as a signal transduction molecule. However, the role of LiaF in signaling and its relationship with LiaX are unknown. METHODS: We generated a liaF null mutant in E. faecalis OG117 by adding four stop codons at amino acid positions 11–14 (OG117liaF*(11-14)) using a CRISPR-Cas9 system. The mutant was complemented by restoring wild-type liaF in its chromosomal location (OG117liaF*(11-14)::liaF). Mutants were confirmed with whole genome sequencing (WGS). Anionic phospholipid (AP) microdomain distribution was assessed on microscopy using 10-N-nonyl-acridine-orange (NAO). LiaFSR activation was assessed by surface expression of LiaX via ELISA. DAP MICs were performed by broth microdilution in the presence/absence of exogenous LiaX (eLiaX). LL37 (50µg/ml) and DAP (1.5µg/ml) killing assays with eLiaX were also performed in triplicate. RESULTS: Truncation of liaF did not have any effect on DAP MICs, AP microdomain distribution or LiaX surface expression compared to OG117. No additional mutations were observed by WGS in the mutants. In the presence eLiaX, DAP MIC increased 8-fold in wild-type OG117 but remained the same (1 µg/mL) in OG117liaF*(11-14). Complementation of liaF restored the increase in DAP MIC in the presence of eLiaX. In the LL37 killing assay, survival of OG117 was significantly increased on the addition of eLiaX (2.9% vs 11.8%, respectively, P < .002). Addition of eLiaX was unable to rescue OG117liaF*(11-14) in the presence of LL-37 (2.4% vs 2.5% respectively, P=0.51), but was able to increase survival in the complemented strain (2.8% vs 7.6%, respectively, P < .002). A similar trend was seen in the DAP killing assay, with increased survival for OG117 (8.7% vs 20%) and OG117liaF*(11-14)::liaF (11.6% vs 17%), but not OG117liaF*(11-14) (0.38% vs 1%). CONCLUSION: LiaF is required for full tolerance to the cathelicidin LL37 and DAP in E. faecalis OG1RF. These results suggest that LiaF may interact with LiaX as a part of the LiaFSR stress response. DISCLOSURES: William R. Miller, MD, Entasis: Grant/Research Support|UpToDate: Honoraria Cesar A. Arias, MD, PhD, Entasis: Grant/Research Support|MeMed Diagnostics Ltd: Grant/Research Support|Merck: Grant/Research Support. Oxford University Press 2022-12-15 /pmc/articles/PMC9752123/ http://dx.doi.org/10.1093/ofid/ofac492.157 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Botero, Diana Panesso
Singh, Kavindra
Gomez-Villegas, Sara-Isabel
Khan, Ayesha
Supande, Adeline
Nguyen, April
Rincon, Sandra
Hood, Kara S
Dinh, An
Deyanov, Alexander
Miller, William R
Shamoo, Yousif
Tran, Cecilia
Arias, Cesar A
2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF
title 2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF
title_full 2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF
title_fullStr 2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF
title_full_unstemmed 2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF
title_short 2350. LiaF is required for LiaX mediated protection against Daptomycin and LL-37 in Enterococcus faecalis OG1RF
title_sort 2350. liaf is required for liax mediated protection against daptomycin and ll-37 in enterococcus faecalis og1rf
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752123/
http://dx.doi.org/10.1093/ofid/ofac492.157
work_keys_str_mv AT boterodianapanesso 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT singhkavindra 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT gomezvillegassaraisabel 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT khanayesha 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT supandeadeline 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT nguyenapril 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT rinconsandra 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT hoodkaras 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT dinhan 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT deyanovalexander 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT millerwilliamr 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT shamooyousif 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT trancecilia 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf
AT ariascesara 2350liafisrequiredforliaxmediatedprotectionagainstdaptomycinandll37inenterococcusfaecalisog1rf